Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1Head & Neck 1

Conditions

Breast Neoplasms 16Carcinoma, Non-Small-Cell Lung 7Rectal Neoplasms 6Colorectal Neoplasms 6Pancreatic Neoplasms 5Lung Neoplasms 5Colonic Neoplasms 5Squamous Cell Carcinoma of Head and Neck 4Carcinoma, Renal Cell 4Urinary Bladder Neoplasms 3Prostatic Neoplasms 3Ovarian Neoplasms 3Neoplasm Metastasis 3Melanoma 3Lymphoma, Follicular 3Head and Neck Neoplasms 3Carcinoma, Ovarian Epithelial 3Breast Neoplasms, Male 3Sezary Syndrome 2Mycosis Fungoides 2Lymphoma, T-Cell, Peripheral 2Lymphoma, Mantle-Cell 2Lymphoma, Large-Cell, Anaplastic 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma, B-Cell, Marginal Zone 2Lymphoma 2Liver Neoplasms 2Leukemia, Lymphocytic, Chronic, B-Cell 2Kidney Neoplasms 2Immunoblastic Lymphadenopathy 2

Interventions

Platinum 2Gemcitabine 2Gefitinib 2Cisplatin 2Cetuximab 21,2-diaminocyclohexaneplatinum II citrate 2vandetanib 1temsirolimus 1linrodostat 1ficlatuzumab 1durvalumab 1cediranib 1adavosertib 1Trioxsalen 1Soybean Proteins 1Sirolimus 1Radiotherapy, Intensity-Modulated 1Phototherapy 1Photochemotherapy 1Pemetrexed 1Paclitaxel 1Nivolumab 1Immunohistochemistry 1Dihematoporphyrin Ether 1Carboplatin 1Biopsy 11-phenyl-3,3-dimethyltriazene 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Lymphoid Interstitial Pneumonia × Immunohistochemistry × Clear all
NCT01414426 2021-01-14

Vandetanib in Preventing Head and Neck Cancer in Patients With Precancerous Head and Neck Lesions

University of Chicago

Phase 2 Completed
20 enrolled 7 charts
Head & NeckOther neoplasm

Lymphoid Interstitial Pneumonia, Squamous Cell Carcinoma of Head and Neck, Precancerous Conditions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡